Antejin Biotech

Chengdu, China Acquired By Fosun Pharmaceutical
Bacterial vaccine development and pharmaceutical services are provided.

About Antejin Biotech

Antejin Biotech is a Healthcare company based in Chengdu (China), and was acquired by Fosun Pharmaceutical in November 2021. Bacterial vaccine development and pharmaceutical services are provided. Its focus areas include Services for Healthcare Providers, BPO, Outsourced Clinical Services and Nuclear Pharmacies.

Company details

Antejin Biotech is located in Chengdu, China, where operations in the biotechnology sector are conducted. Bacterial vaccine development is focused on, alongside pharmaceutical services for research and production. The company serves clients through specialized expertise in infectious disease solutions and drug formulation. Activities are centered on advancing vaccine technologies and supporting pharmaceutical pipelines in the region. The domain antejinbiotech.tcc.mode is utilized for online presence.

  • Headquarters Chengdu, China
  • Stage Acquired
  • Sectors
    Healthcare
  • Acquired by Fosun Pharmaceutical (Nov 2021)
Key Metrics

Investors in Antejin Biotech

Antejin Biotech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Fosun Pharmaceutical.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Research, development, production, and sale of pharmaceuticals are provided.
1994fosunpharma.comShanghai, China
Premium access

Investor details for Antejin Biotech

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Antejin Biotech

Antejin Biotech is headquartered in Chengdu, China. It is registered at Chengdu, Sichuan, China.

Antejin Biotech is located in Chengdu, China, where operations in the biotechnology sector are conducted. Bacterial vaccine development is focused on, alongside pharmaceutical services for research and production. The company serves clients through specialized expertise in infectious disease solutions and drug formulation. Activities are centered on advancing vaccine technologies and supporting pharmaceutical pipelines in the region. The domain antejinbiotech.tcc.mode is utilized for online presence.

Antejin Biotech has 1 investor. Key investors include Fosun Pharmaceutical.

Yes. Antejin Biotech was acquired by Fosun Pharmaceutical in November 2021.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available